Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 95% —
Register , to see more distinctive signs of diseases and studies — 82%
cirrhosis of the liver
88%
—
amoebiasis —
74%
liver amyloidosis
88%
—
giardiasis —
74%
glycogenoses
82%
—
vomiting bile —
72%
obesity
81%
—
nausea after eating —
66%
dystrophy
78%
—
feeling of heaviness in the lower abdomen —
64%
hepatic coma
78%
—
bitterness in the mouth in the morning —
61%
empty
72%
—
nausea is worse after eating —
61%
obesity 2 st
71%
—
vomiting —
61%
violation of carbohydrate metabolism
70%
—
in the morning unpleasant taste in the mouth —
60%
hepatitis b
69%
—
heaviness in the lower abdomen —
59%
liver dysfunction
68%
—
hypofibrinogenemia —
56%
overweight
68%
—
yellow stool —
55%
amyloidosis
65%
—
belching with bile —
55%
coma
64%
—
congestion belching —
55%
reduction of LDL
60%
—
belching bitter —
55%
abdominal obesity
59%
—
feces are grayish-white in color —
52%
reduction of HDL
58%
—
increased indirect bilirubin —
52%
reduction of ggtp
56%
—
yellow skin color —
51%
hepatosis fatty
100%
42%
light chair —
51%
hepatoses
98%
41%
appetite immediately after eating —
51%
liver atrophy
98%
41%
worse after eating —
50%
increase ggtp
55%
—
feeling of heaviness in the stomach —
50%
hepatic encephalopathy
54%
—
yellow feces —
49%
blood diseases
52%
—
of pure hypercholesterolemia —
48%
intrahepatic cholestasis
51%
—
burping with food —
48%
portal hypertension
51%
—
familial endogenous hypertriglyceridemia —
48%
reduction of tg
51%
—
bach flower —
48%
food poisoning
51%
—
bitterness in the mouth —
47%
type 2 diabetes mellitus
50%
—
no appetite —
47%
insulin deficiency
50%
—
yellowness of mucous membranes —
46%
excess insulin
50%
—
cytolysis syndrome
54%
100%
patient's condition
50%
—
primary hypercholesterolemia —
45%
increased adiponectin
50%
—
worse before eating —
45%
consequences of taking medications
50%
—
heaviness in the abdomen —
44%
increased HDL
50%
—
vomiting food —
43%
lower cholesterol
50%
—
food is poorly digested —
42%
hepatic cell carcinoma
50%
—
abdominal discomfort —
41%
dyslipidemia
50%
—
nose headache from fatigue —
41%
violation of fat metabolism
49%
—
no feeling of hunger —
41%
hyperammonemia
49%
—
appetite increased —
41%
grandmother diabetes
48%
—
make the main —
40%
alt reduction
48%
—
headache with weakness —
39%
reduction of ast
48%
—
helminths —
37%
consequences of infection
48%
—
nausea
17%
54%
bacterial overgrowth syndrome
48%
—
jaundice
28%
64%
increased cholesterol levels in the blood
47%
—
destructive behavior —
34%
lipid metabolism
47%
—
traumatic illness —
34%
liver is indurated
46%
—
general intoxication syndrome —
33%
polymorbidity
46%
—
vascular damage —
33%
protein with increased
45%
—
immunodeficiency —
32%
mushroom poisoning
44%
—
headaches —
31%
antinuclear factor
44%
—
heaviness in the hypochondrium
35%
65%
encephalopathy
44%
—
enlarged liver
42%
69%
increased ferritin
43%
—
aching pain in the right hypochondrium
29%
54%
diffuse liver changes
43%
—
polypragmasy
26%
49%
alcoholic liver disease
43%
—
hyperbilirubinemia
22%
40%
liver pain
43%
—
independent
20%
37%
chronic liver failure
43%
—
aches
20%
36%
cardiac cirrhosis of the liver
42%
—
gallbladder stones
44%
58%
increased fatigue
42%
—
acute pain
16%
30%
consumes alcohol
42%
—
cholestatic hepatitis
40%
53%
total blood protein
42%
—
bursting pain in the right hypochondrium
41%
54%
nitrate poisoning
42%
—
heaviness in the right hypochondrium
38%
50%
inflammatory bowel diseases
41%
—
heaviness in the liver
33%
44%
sensitivity to medications
41%
—
abdominal distension
36%
47%
worse from mushrooms
41%
—
abdominal distension a
35%
46%
hypertension
41%
—
pain in the right hypochondrium
32%
42%
varicose veins of the esophagus
41%
—
increased ast
31%
41%
omega vaccinations
40%
—
bursting
31%
41%
fibromyalgia
40%
—
worse food
26%
35%
fear of water
40%
—
viral hepatitis c
70%
79%
blindness
39%
—
increased cholesterol
46%
54%
benign neoplasms
39%
—
hepatitis
67%
75%
heart dysfunction
39%
—
swelling
22%
29%
deep coma
39%
—
there are no complaints
35%
41%
IBS
39%
—
chronic viral hepatitis
58%
63%
fermentopathy
39%
—
hepatitis chronic
58%
63%
protein reduced
39%
—
hypertrophy biliary tract
67%
72%
metabolic alkalosis
38%
—
increased alt
37%
40%
decrease in atherogenicity
38%
—
functional disorders of the stomach
29%
32%
atherosclerosis of blood vessels
38%
—
medicinal hepatitis
40%
43%
diabetes mellitus
38%
—
digestive disorders
31%
33%
metabolic disorder
38%
—
weakness
27%
29%
feeling of isolation
37%
—
cholestasis
72%
74%
expansion of the esophagus
37%
—
anomalies of esophageal development
37%
—
hormonal disorders
37%
—
viral hepatitis d
37%
—
red palms
37%
—
hypertension
37%
—
decreased lipase
37%
—
thickness of posterior wall of left ventricle is increased
36%
—
cancer
36%
—
insulin resistance index decreased
36%
—
up circulatory disorders
36%
—
biliary cirrhosis of the liver
36%
—
congenital liver fibrosis
36%
—
alkalosis
36%
—
alcohol is abusing
36%
—
angiopathy
36%
—
adiponectin reduced
36%
—
damage to the nervous system
35%
—
tumors of the heart
35%
—
reduction of ldh
35%
—
cardiac disorder
35%
—
intestinal infection
35%
—
vascular tumor
35%
—
lower triglycerides
34%
—
ascites
34%
—
impaired glucose tolerance
34%
—
impaired function of the large intestine
34%
—
onset of illness
34%
—
de nol
34%
—
inflammation of the stomach
33%
—
antibodies to smooth muscle
33%
—
liver necrosis
33%
—